ZYDUSLIFE

Zydus Lifesciences, a prominent player in the pharmaceuticals and drugs industry, experienced a notable decline in its stock price on February 19, 2025, with a loss of 4.93%. The stock reached a new 52-week low of Rs. 862.2 during the trading session, marking a significant downturn. Today’s performance saw Zydus Lifesciences underperforming its sector by 2.25%, continuing a trend of consecutive declines over the past two days, during which it has recorded a total drop of 4.81%. The stock touched an intraday low of Rs. 862.2, reflecting a decrease of 5.58% at its lowest point. The trading day was characterized by high volatility, with an intraday volatility rate of 21.19%. Additionally, Zydus Lifesciences is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past month, the stock has declined by 12.67%, contrasting with the Sensex, which has seen a modest decrease of 1.26%.